Here, we report a case of acute myelomonocytic leukemia with a double mutation to the CCAAT/enhancer-binding protein alpha (CEBPA) gene during maintenance therapy for APL and include a review of the current literature. Here, CEBPA is linked to acute promyelocytic leukemia.